Purpose <p>High-grade clear cell renal cell carcinoma (ccRCC) is linked to lower survival rates and more aggressive disease progression. This study aims to assess the diagnostic performance of MRI-derived radiomics as a non-invasive approach for pre-operative differentiation of high-grade from low-grade ccRCC.</p> Methods <p>A systematic search was conducted across PubMed, Scopus, and Embase. Quality assessment was performed using QUADAS-2 and METRICS. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the curve (AUC) were estimated using a bivariate model. Separate meta-analyses were conducted for radiomics models and combined models, where the latter integrated clinical and radiological features with radiomics. Subgroup analysis was performed to identify potential sources of heterogeneity. Sensitivity analysis was conducted to identify potential outliers.</p> Results <p>A total of 15 studies comprising 2,265 patients were included, with seven and six studies contributing to the meta-analysis of radiomics and combined models, respectively. The pooled estimates of the radiomics model were as follows: sensitivity, 0.78; specificity, 0.84; PLR, 4.17; NLR, 0.28; DOR, 17.34; and AUC, 0.84. For the combined model, the pooled sensitivity, specificity, PLR, NLR, DOR, and AUC were 0.87, 0.81, 3.78, 0.21, 28.57, and 0.90, respectively. Radiomics models trained on smaller cohorts exhibited a significantly higher pooled specificity and PLR than those trained on larger cohorts. Also, radiomics models based on single-user segmentation demonstrated a significantly higher pooled specificity compared to multi-user segmentation.</p> Conclusion <p>Radiomics has demonstrated potential as a non-invasive tool for grading ccRCC, with combined models achieving superior performance.</p> Graphical Abstract <p></p>